Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A Concise Guide to Nuclear MedicineTherapeutic Applications of Nuclear Medicine

A Concise Guide to Nuclear Medicine: Therapeutic Applications of Nuclear Medicine [Therapeutic applications of nuclear medicine are expanding (Table 11.1). The radioisotopes in therapy were limited predominantly to treatment of hyperthyroidism and thyroid cancer, and polycythemia rubra vera for many years. Strontium 89 (Sr-89), rhenium 186 (Re-186), samarium 153 (Sm-153), and tin 117 m (Sn-117) have been increasingly used recently in treating bone pain secondary to metastases. Additionally, treatment of certain neuroendocrine tumors with I-131 MIBG and labeled octreotide and pentreotide, the use of radiolabeled monoclonal antibodies for lymphomas, and radionuclide synovectomy has revolutionized the field of therapeutic nuclear medicine.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

A Concise Guide to Nuclear MedicineTherapeutic Applications of Nuclear Medicine

Download PDF
8 pages

Loading next page...
 
/lp/springer-journals/a-concise-guide-to-nuclear-medicine-therapeutic-applications-of-20A6CSNzgN
Publisher
Springer Berlin Heidelberg
Copyright
© Springer-Verlag Berlin Heidelberg 2011
ISBN
978-3-642-19425-2
Pages
143 –150
DOI
10.1007/978-3-642-19426-9_11
Publisher site
See Chapter on Publisher Site

Abstract

[Therapeutic applications of nuclear medicine are expanding (Table 11.1). The radioisotopes in therapy were limited predominantly to treatment of hyperthyroidism and thyroid cancer, and polycythemia rubra vera for many years. Strontium 89 (Sr-89), rhenium 186 (Re-186), samarium 153 (Sm-153), and tin 117 m (Sn-117) have been increasingly used recently in treating bone pain secondary to metastases. Additionally, treatment of certain neuroendocrine tumors with I-131 MIBG and labeled octreotide and pentreotide, the use of radiolabeled monoclonal antibodies for lymphomas, and radionuclide synovectomy has revolutionized the field of therapeutic nuclear medicine.]

Published: Mar 26, 2011

Keywords: Neuroendocrine Tumor; Differentiate Thyroid Cancer; Peptide Receptor Radionuclide Therapy; Radionuclide Therapy; Villonodular Synovitis

There are no references for this article.